Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 291-296

  Haller, Hermann ^a,c   Ziegler, Eva Maria ^a   Homuth, Volker ^a   Drab, Marek ^a   Eichhorn, Jens ^a   Nagy, Zsuzsanna ^a   Busjahn, Andreas ^a   Vetter, Klaus ^b   Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c Franz Volhard Klinik   (Germany)

Author keywords

adhesion molecules; endothelial cells; ICAM; integrins; leukocytes; preeclampsia; VCAM

Indexed keywords

BETA1 INTEGRIN; CALCIUM ION; CD11B ANTIGEN; CD18 ANTIGEN; GLYCOPROTEIN P 15095; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031037544     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.291     Document Type: Article

References (42)

1. Haller H, Eichhorn J, Pieper K, Göbel U, Luft FC. Leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol. 1996; 7:40-48.
2. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol. 1991;18:661-682.
3. Lindheimer MD, Katz AI. Preeclampsia: pathophysiology, diagnosis, and management. Annu Rev Med. 1989;40:233-250.
4. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semm Perinatol. 1991; 15:86-93.
5. Saleh AA, Bottoms SF, Norman G, Farag A, Mammen EF. Hemostasis in hypertensive disorders of pregnancy. Obstet Gynecol. 1988;71:719-722.
6. Graeff H, von Hugo R, Schrock R. Recent aspects of hemostasis, hematology and hemorheology in preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1984;17:91-102.
7. Perry KG Jr, Martin JN Jr. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol. 1992;35: 338-350.
8. Weiner CP. Preeclampsia-eclampsia syndrome and coagulation. Clin Perinatol. 1991;18:713-726.
9. Bhatia RK, Bottoms SF, Saleh AA, Norman GS, Mammen EF, Sokol RJ. Mechanisms for reduced colloid osmotic pressure in preeclampsia. Am J Obstet Gynecol. 1987;157:106-108.
10. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4:700-708.
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder [see comments]. Am J Obstet Gynecol. 1989;161:1200-1204.
12. Mastrogiannis DS, Kalter CS, O'Brien WF, Carlan SJ, Reece EA. Effect of magnesium sulfate on plasma endothelin-1 levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol. 1992;167: 1554-1559.
13. Taylor RN, Varma M, Teng NN, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 1990;71:1675-1677.
14. Taylor RN, Heilbron DC. Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol. 1990;163:1839-1844.
15. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol. 1991;165: 895-901.
16. Friedman SA, de Groot CJ, Taylor RN, Golditch, BD, Roberts JM. Plasma cellular fibronectin as a measure of endothehal involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:838-841.
17. Calvin S, Weinstein L, Witte MH, Finley PR. Plasma levels of fibronectin and prostacyclin metabolite in peripartum preeclamptic women. Am J Perinatol. 1990;7:125-129.
18. Chen CK, Lee CN, Shyu MK, Hwa HL, Chen CD, Sheu BC, Hsieh FJ. Fibronectin levels in normal pregnancy and preeclampsia. J Formos Med Assoc. 1994;93:921-924.
19. de Jager CA, Shephard EG, Robson SC, Jaskiewicz K, Froese S, Anthony J, Kirsch RE. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med. 1995;125:522-530.
20. Shiiki H, Nishino T, Uyama H, Kimura T, Nishimoto K, Hashimoto T, Fujii Y, Dohi K. Alterations in extracellular matrix components and integrins in patients with preeclamptic nephropathy. Virchows Arch. 1996;427:567-573.
21. Stubbs TM, Lazarchick J, Horger EO. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984;150:885-887.
22. Robson JS. Proteinuria and the renal lesion in preeclampsia and abruptio placentae. Perspect Nephrol Hypertens. 1976;5:61-73.
23. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
24. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin Hypertension. 1996;27:56-61.
25. Baker PN, Davidge ST, Roberts JM. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension. 1995;26:244-248.
26. Davidge ST, Baker PN. Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol. 1995;269:H1106-H1112.
27. Roberts JM, Edep ME, Goldfien A, Taylor RN. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol. 1992;27:101-108.
28. Taylor RN, Musci TJ, Rodgers GM, Roberts JM. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am J Reprod Immunol. 1991;25:105-108.
29. Taylor RN, Casal DC, Jones LA, Varma M, Martin JN Jr, Roberts JM. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstet Gynecol. 1991; 165:1705-1710.
30. Haller H, Oeney T, Hauck U, Distler A, Philipp T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens. 1989;2:238-243.
31. ++), in human endothelial cells and augments thrombin-induced cell signalling. J Lab Clin Med. 1994;124:
32. Haller H, Schaper D, Ziegler W. Philipp S, Kuhlmann M, Distler A, Luft FC. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension. 1995; 25:511-516.
33. Gallery ED, Rowe J, Campbell S, Hawkins T. Effect of serum on secretion of prostacyclin and endothelin-1 by decidual endothelial cells from normal and preeclamptic pregnancies. Am J Obstet Gynecol. 1995;173:918-923.
34. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res. 1991;63:363-372.
35. Saleh AA, Bottoms SF, Farag AM, Dombrowski MP, Welch RA, Norman G, Mammen EF. Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet. 1992; 251:105-110.
36. Musci TJ, Roberts JM, Rodgers GM, Taylor RN. Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am J Obstet Gynecol. 1988;159:1446-1451.
37. Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem. 1991;266:17815-2.
38. Rosen P, Schwippert B, Tschope D. Adhesive proteins in platelet-endothelial interactions. Eur J Clin Invest. 1994;24(suppl 1):21-24.
39. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? [see comments]. Br J Obstet Gynaecol. 1994;101: 485-487.
40. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937-940.
41. Thilaganathan B, Makrydimas G, Plachouras N, Nicolaides KH. Neutrophil and monocyte beta 2-integrin expression in maternal and fetal blood. Am J Obstet Gynecol. 1995;172:58-62.
42. Crouch SP, Crocker IP, Fletcher J. The effect of pregnancy on polymorphonuclear leukocyte function. J Immunol. 1995;155: 5436-5443.